EUVIMEDEUVIMED entdecken
Crossref

An integrated cellular and molecular model of gastric neuroendocrine cancer evolution highlights therapeutic targets

Joscha Griger, Sebastian A Widholz, Moritz Jesinghaus, Niklas de Andrade Krätzig, Sebastian Lange, Thomas Engleitner, Juan José Montero, Ekaterina Zhigalova, Rupert Öllinger, Veveeyan Suresh, Wiebke Winkler, Svenja Lier und 24 weitere

Cancer Cell · 2023-07 · 41 (7) · 1327-1344.e10

DOI: 10.1016/j.ccell.2023.06.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2023-07. Verfasst von Joscha Griger und 35 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Oncology and Functional Genomics, School of Medicine, Technische Universität München, 81675 Munich, Germany; Center for Transl…. Hauptthemen laut MEDLINE: Carcinoma, Neuroendocrine, Stomach Neoplasms, Neuroendocrine Tumors. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 125 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric neuroendocrine carcinomas (G-NEC) are aggressive malignancies with poorly understood biology and a lack of disease models. Here, we use genome sequencing to characterize the genomic landscapes of human G-NEC and its histologic variants. We identify global and subtype-specific alterations and expose hitherto unappreciated gains of MYC family members in a large part of cases. Genetic engineering and lineage tracing in mice delineate a model of G-NEC evolution, which defines MYC as a critical driver and positions the cancer cell of origin to the neuroendocrine compartment. MYC-driven tumors have pronounced metastatic competence and display defined signaling addictions, as revealed by large-scale genetic and pharmacologic screening of cell lines and organoid resources. We create global maps of G-NEC dependencies, highlight critical vulnerabilities, and validate therapeutic targets, including candidates for clinical drug repurposing. Our study gives comprehensive insights into G-NEC biology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, NeuroendocrineStomach NeoplasmsNeuroendocrine TumorsHumansAnimalsMiceModels, Molecular

Stichwörter der Autor:innen

CRISPR screenMANECNECWGSgastric cancergenetic screeningmouse modelneuroendocrine cancerpharmacologic screeningstomach

Autor:innen und Institutionen

  • Institute of Molecular Oncology and Functional Genomics, School of Medicine, Technische Universität München, 81675 Munich, Germany; Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technische U…
  • Institute of Pathology, School of Medicine, Technische Universität München, Munich 81675, Germany; Institute of Pathology, Philipps University Marburg and University Hospital Marburg (UKGM), Marburg, Germany; Institute…
  • Immune Regulation and Cancer, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin 13125, Germany.
  • Department of Medicine II, Klinikum rechts der Isar, School of Medicine, Technische Universität München, 81675 Munich, Germany.
  • Institute of Molecular Oncology and Functional Genomics, School of Medicine, Technische Universität München, 81675 Munich, Germany.
  • Institute of Molecular Oncology and Functional Genomics, School of Medicine, Technische Universität München, 81675 Munich, Germany; German Cancer Consortium (DKTK), Heidelberg 69120, Germany; Department of Medicine II,…

Zitieren

APA

Griger, J., Widholz, S. A., Jesinghaus, M., de Andrade Krätzig, N., Lange, S., Engleitner, T., Montero, J. J., Zhigalova, E., Öllinger, R., Suresh, V., Winkler, W., Lier, S., Baranov, O., Trozzo, R., Ben Khaled, N., Chakraborty, S., Yu, J., Konukiewitz, B., Steiger, K., …, & Rad, R. (2023). An integrated cellular and molecular model of gastric neuroendocrine cancer evolution highlights therapeutic targets. Cancer Cell, 41(7), 1327-1344.e10. https://doi.org/10.1016/j.ccell.2023.06.001

Vancouver

Griger J, Widholz SA, Jesinghaus M, de Andrade Krätzig N, Lange S, Engleitner T, et al. An integrated cellular and molecular model of gastric neuroendocrine cancer evolution highlights therapeutic targets. Cancer Cell. 2023;41(7):1327-1344.e10. doi:10.1016/j.ccell.2023.06.001

BibTeX
@article{Griger2023,
  author = {Griger, Joscha and Widholz, Sebastian A and Jesinghaus, Moritz and de Andrade Krätzig, Niklas and Lange, Sebastian and Engleitner, Thomas and Montero, Juan José and Zhigalova, Ekaterina and Öllinger, Rupert and Suresh, Veveeyan and Winkler, Wiebke and Lier, Svenja and Baranov, Olga and Trozzo, Riccardo and Ben Khaled, Najib and Chakraborty, Shounak and Yu, Jiakun and Konukiewitz, Björn and Steiger, Katja and Pfarr, Nicole and Rajput, Ashish and Sailer, David and Keller, Gisela and Schirmacher, Peter and Röcken, Christoph and Fagerstedt, Klaus W and Mayerle, Julia and Schmidt-Supprian, Marc and Schneider, Günter and Weichert, Wilko and Calado, Dinis P and Sommermann, Thomas and Klöppel, Günter and Rajewsky, Klaus and Saur, Dieter and Rad, Roland},
  title = {An integrated cellular and molecular model of gastric neuroendocrine cancer evolution highlights therapeutic targets},
  journal = {Cancer Cell},
  year = {2023},
  volume = {41},
  number = {7},
  pages = {1327--1344.e10},
  doi = {10.1016/j.ccell.2023.06.001}
}
Kostenlos starten →